Intestinal immune responses in wild-type and Apcmin/+ mouse, a model for colon cancer
- PMID: 12941845
Intestinal immune responses in wild-type and Apcmin/+ mouse, a model for colon cancer
Abstract
C57BL/6J Apc(Min/+) (Apc(Min/+)) mice spontaneously develop pretumoric adenomas into the intestinal mucosa. We studied the relationship between the intestinal immune responses and adenoma formation in Apc(Min/+) mice and compared Apc(Min/+) mice with their wild-type siblings. Three time points (5, 8, and 15 weeks of age) and three high-fat dietary treatments (a non-fiber control with beef or inulin amendment) were included. The numbers of CD8+ T lymphocytes and tissue macrophages (Mac-1+ cells) per villus in ileal mucosa were determined by immunohistology, and the concentrations of secretory IgA, residual prostaglandin E(2) (PGE(2)), tumor necrosis factor alpha, and interleukin (IL)-12 in ileal contents were analyzed by ELISA. The crypt-villus ratio of the ileal mucosa was determined histologically. An immunostimulation, characterized by an increase in several parameters (PGE(2), IgA, Mac-1, and CD8), was observed in both genotypes between weeks 5 and 8. Most of the adenomas in Apc(Min/+) mice also appeared during the same period of sexual maturation. Females had smaller adenomas than males, and the beef group had fewer and smaller adenomas than the control group at 15 weeks. Females had less IgA and fewer Mac-1+ and CD8+ cells in ileal tissue than males at 15 weeks and more luminal IL-12 than males at 8 weeks. Puberty may have affected both tumorigenesis and intestinal immune responses in the Apc(Min/+) mouse. The beef group showed less luminal IgA and tumor necrosis factor alpha but more IL-12 than the control group. The concentration of PGE(2) correlated positively with the number and size of adenomas and was higher in the Apc(Min/+) mice than in wild-type mice at 15 weeks. IgA and Mac-1 were positively correlated with the size of adenomas at 15 weeks. The positive correlations between tumor size and IgA and between tumor number and size and PGE(2) suggest that a balance toward the Th2 type immune response may affect the pace of tumorigenesis in this model. The general similarity of the intestinal immune responses in both genotypes and the lack of intestinal inflammation in the Apc(Min/+) mice suggest that the mutation in the adenomatous polyposis coli gene does not lead to major alterations in intestinal immune function and that the intestinal immunology does not explain tumorigenesis in the Apc(Min/+) mouse model.
Similar articles
-
R-flurbiprofen chemoprevention and treatment of intestinal adenomas in the APC(Min)/+ mouse model: implications for prophylaxis and treatment of colon cancer.Cancer Res. 1997 Oct 1;57(19):4316-24. Cancer Res. 1997. PMID: 9331093
-
Effects of dietary folate on intestinal tumorigenesis in the apcMin mouse.Cancer Res. 2000 Oct 1;60(19):5434-40. Cancer Res. 2000. PMID: 11034085
-
Suppression of intestinal polyps in Msh2-deficient and non-Msh2-deficient multiple intestinal neoplasia mice by a specific cyclooxygenase-2 inhibitor and by a dual cyclooxygenase-1/2 inhibitor.Cancer Res. 2001 Aug 15;61(16):6131-6. Cancer Res. 2001. PMID: 11507063
-
The intestinal epithelium and its neoplasms: genetic, cellular and tissue interactions.Philos Trans R Soc Lond B Biol Sci. 1998 Jun 29;353(1370):915-23. doi: 10.1098/rstb.1998.0256. Philos Trans R Soc Lond B Biol Sci. 1998. PMID: 9684289 Free PMC article. Review.
-
Apc mice: models, modifiers and mutants.Pathol Res Pract. 2008;204(7):479-90. doi: 10.1016/j.prp.2008.03.004. Epub 2008 Jun 5. Pathol Res Pract. 2008. PMID: 18538487 Review.
Cited by
-
Dual Targeting of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase and Histone Deacetylase as a Therapy for Colorectal Cancer.EBioMedicine. 2016 Aug;10:124-36. doi: 10.1016/j.ebiom.2016.07.019. Epub 2016 Jul 17. EBioMedicine. 2016. PMID: 27448759 Free PMC article.
-
Large intestine intraepithelial lymphocytes from Apc+/+ and Apc+/Min mice and their modulation by indigestible carbohydrates: the IL-15/IL-15R alpha complex and CD4+ CD25+ T cells are the main targets.Cancer Immunol Immunother. 2005 Jan;54(1):78-86. doi: 10.1007/s00262-004-0543-7. Cancer Immunol Immunother. 2005. PMID: 15693142 Free PMC article.
-
Colitis-associated cancer: the role of T cells in tumor development.Semin Immunopathol. 2009 Jul;31(2):249-56. doi: 10.1007/s00281-009-0161-8. Epub 2009 Jun 3. Semin Immunopathol. 2009. PMID: 19495757 Review.
-
The induction of S100p expression by the Prostaglandin E₂ (PGE₂)/EP4 receptor signaling pathway in colon cancer cells.Cancer Biol Ther. 2010 Nov 15;10(10):1056-66. doi: 10.4161/cbt.10.10.13373. Epub 2010 Nov 15. Cancer Biol Ther. 2010. PMID: 20890108 Free PMC article.
-
Colorectal cancer prevention: Immune modulation taking the stage.Biochim Biophys Acta Rev Cancer. 2018 Apr;1869(2):138-148. doi: 10.1016/j.bbcan.2017.12.002. Epub 2018 Jan 31. Biochim Biophys Acta Rev Cancer. 2018. PMID: 29391185 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous